The effects of caffeine consumption on delayed conception were evaluated in a European multicenter study on risk factors of infertility. Information was collected retrospectively on time of unprotected intercourse for the first pregnancy and the most recent waiting time episode in a randomly selected sample of 3,187 women aged 25-44 years from five European countries (Denmark, Germany, Italy, Poland, and Spain) between August 1991 and February 1993. The consumption of caffeinated beverages at the beginning of the waiting time was used to estimate daily caffeine intake, which was categorized as 0-100, 101-300, 301-500, and >501 mg. Risk of subfecundity (>9.5 months) and the fecundability ratio, respectively, were assessed by logistic regression and Cox proportional hazard analyses, adjusting for age, parity, smoking, alcohol consumption, frequency of intercourse, educational level, working status, use of oral contraceptives, and country. A significantly increased odds ratio (OR) of 1.45 (95% confidence interval (Cl) 1.03-2.04) for subfecundity in the first pregnancy was observed for women drinking more than 500 mg of caffeine per day, the effect being relatively stronger in smokers (OR = 1.56, 95% Cl 0.92-2.63) than in nonsmokers (OR = 1.38, 95% Cl 0.85-2.23). Women in the highest level of consumption had an increase in the time leading to the first pregnancy of 11 % (hazard ratio = 0.90, 95% Cl 0.78-1.03). These associations were observed consistently in all countries as well as for the most recent waiting time episode. The authors conclude that high levels of caffeine intake may delay conception among fertile women. Am J Epidemiol 1997; 145:324-34. caffeine; infertility; risk factors
studies were too high to be compared with human doses. In general, the effects of caffeine on fertility and reproduction in rodents are limited and appear to be restricted mainly to an increased time to pregnancy (TTP) and lower birth weight (3, 8, 9) . Nevertheless, differences in the metabolism of caffeine between rodents and humans, particularly in the uneven proportion of caffeine metabolites that are trimethyl derivatives (1, 10) , make the extrapolation of caffeine effects from animals to humans difficult (11) (12) (13) .
Several studies on human beings have reported an association between caffeine intake and delayed TTP (14) (15) (16) (17) (18) (19) (20) , whereas others have shown either no association or association only at very high levels of consumption (20) (21) (22) (23) . These discrepancies in study results have been attributed to recruitment of selected groups of subjects, different precision in measuring coffee consumption and intake of other sources of caffeine, differences in brewing methods, and lack of control for potentially confounding variables (24) (25) (26) (27) .
In each country, coffee consumption patterns are influenced by lifestyle, culture, tradition, and behavior (28) . Within Europe, coffee brewing methods and drinking habits differ widely between the northern and southern countries. Whereas filtering coffee is the most popular brewing method in the north, mocha and espresso coffee are used predominantly in Italy and Spain. These differences in brewing methods result in different efficiency in caffeine extraction (28) , which is greater (97-100 percent) for filter coffee. The different types of coffee (e.g., robusta, arabica) and cup sizes (small cups, mugs, and so forth) generally used in each country also account for differences in caffeine content per cup of coffee. The stronger coffee is used in the south, but in small cups; and the weaker coffee is used in the north in mugs. As a result of these variables acting in different directions, the estimated average caffeine content per cup of coffee does not differ much among the different countries. However, in spite of the small variation in the average content per cup, the frequency of consumption is very different, resulting in a marked downward gradient in the average daily caffeine intake from northern to southern Europe. This wide range of exposure permits comparisons that would prove very difficult to carry out in any single country.
Taking into account these peculiarities, the relation between self-reported coffee/caffeine consumption and delayed TIP was evaluated, among women who were trying to become pregnant, in the context of a population-based European study on putative risk factors for infertility and subfecundity.
MATERIALS AND METHODS
A detailed description of subjects and methods has been reported elsewhere (29) . Briefly, women aged 25-44 years from five European countries (Denmark, Germany, Italy, Poland, and Spain) were randomly selected from population registers, census registers, and electoral rolls. Between August 1991 and February 1993, a total of 6,630 women were interviewed. Participation rates ranged from 54 to 88 percent, with a 68 percent overall participation rate.
Information was collected retrospectively by personal interview on sociodemographic factors, contraceptive use, sexual activity, reproductive history, cigarette smoking, caffeinated beverages, alcohol consumption, and TIP. The questionnaire contained questions on exposures at the starting time of unprotected sexual intercourse covering both the first and the most recent waiting time. Questions on exposures also included the partner when appropriate.
All women were asked how many cups of coffee and tea they drank per day as well as how many glasses/bottles of cola. It was assumed that there were 50 mg of caffeine per cup of tea, and 40 mg in cola drinks. Each person's caffeine intake from coffee was estimated after taking into account the average cup size, the different coffee mixtures, and the different coffee brewing methods used in each of the participating countries (24, 28) . Accordingly, it was estimated that a cup of coffee had an average caffeine content of 130 mg in Denmark, based on a 3.5:1 ratio of consumption of arabica (1.1 percent caffeine) versus robusta coffee (2.2 percent caffeine), the use of filter coffee (97-100 percent extraction efficiency) as the most common brewing method, and a 190-ml cup size (28) . In southern Europe, the estimated average caffeine content per cup of 115 mg was based on a 1:1 arabica to robusta ratio, the use of espresso (80 percent extraction efficiency) and mocha coffee (92-98 percent extraction efficiency), and a usual cup size of 35-50 ml (28) . In Germany, although the most common brewing method and cup size were similar to those in Denmark, the 8:1 ratio between arabica and robusta coffee (28) yielded an estimated average caffeine content of 115 mg per cup.
Total caffeine intake in milligrams per day was categorized into four levels: 0-100, 101-300, 301-500, and >501. Coffee consumption was measured as cups of coffee per day and categorized into four levels: none, one to two, three to four, and five or more.
Alcohol consumption was added up from specific questions on each type of alcohol and measured in number of drinks per week. Cigarette smoking was measured as number of cigarettes per day and later grouped into the following categories: none, one to 10, and 11 or more.
The relations between fertility and coffee and caffeine consumption were assessed using the reported IIP. TTP was measured in months and calculated as the time between stopping a birth control method and time of conception. In fact, TTP was estimated from the following question: "How many months did it take you to become pregnant? That is, how many months were you having sexual intercourse without doing anything to avoid pregnancy?"
The variable TTP was categorized in months as 0-3.4, 3.5-9.4, 9.5-15.4 and >15.5. Although several analyses were carried out using these different cutoff points, only the results based on the cutoff point of 9.5 months are presented in the tables. The threshold was set at 9.5 months to avoid digit preference clustering and to remain below the eligibility criterion for treatment (>12 months), which would censor the observed TTP.
Although the analysis was based mainly on the first pregnancy, the relations between fertility and coffee and caffeine consumption were assessed using the reported TTP for both the first waiting time episode, which included only women who finally became pregnant, and the most recent waiting time. Data from the most recent waiting time were censored in the sense that unsuccessful waiting times were also included in the analyses. Both analyses were restricted to those women who had planned their pregnancies and had not been treated for infertility, since only those women had well-defined TTPs.
Use of oral contraceptives within 12 months prior to the starting time, mother's education, working status (not working, part-time job, full-time job), alcohol consumption, cigarette smoking, frequency of sexual intercourse, history of pelvic inflammatory diseases, parity, and age were considered as potential confounders. To calculate the risk of delayed conception in relation to caffeine and coffee consumption, adjusted odds ratios were estimated through a multivariate logistic regression analysis using TTP as a dichotomous variable (>9.5 months). The analysis was performed for all countries together (stratified by smoking status) and for each individual country using the most appropriate model based on a 10 percent "change-inestimate" confounder-selection strategy (30) . Adjusted fecundity ratios were calculated for risk factors and confounding variables by means of a Cox proportional hazards model for continuous data, following a similar selection strategy as described for the multivariate logistic models. The proportional risk assumption was verified for all the variables included in the model. The statistical analysis was done using an SPSS software package (31) .
RESULTS
Of the 6,630 women who were interviewed, 1,567 had never been pregnant; 3,187 reported that their first pregnancy was planned and were therefore included in the first pregnancy analysis. For the analysis of the most recent waiting time, 3,092 women were finally included.
Concerning the exposure, approximately 80 percent of all women reported drinking at least one cup of coffee per day at the start of the waiting time leading to the first pregnancy. Consumption was greatest in Denmark, where more than 40 percent of women reported drinking five or more cups of coffee per day, and least in Poland, where only 2.1 percent reported that level of coffee drinking. The average daily caffeine intake was 707 mg in Denmark (83.8 percent from coffee, 15.5 percent from tea, and 0.7 percent from cola); 353 mg in Germany (86.7 percent from coffee, 10.5 percent from tea, and 2.8 percent from cola); 278 mg in Poland (41.7 percent from coffee, 55.7 percent from tea, and 2.6 percent from cola); 286 mg in northern Italy (90.6 percent from coffee, 6.2 percent from tea, and 3.2 percent from cola); 256 mg in southern Italy (93.7 percent from coffee, 3.5 percent from tea, and 2.8 percent from cola); 199 mg in Spain (94.6 percent from coffee, 1.9 percent from tea, and 3.5 percent from cola).
In table 1, the frequency distribution of TTP in months according to the women's coffee consumption and caffeine intake is shown, together with the mean and median TTP values for each level. The distribution was very similar for coffee and caffeine based on the levels of exposure adopted; and significantly longer periods of waiting time for increasing levels of coffee and caffeine intake were found.
In table 2, the concordance between the different levels of exposure as measured by coffee or caffeine is shown. Although the categories were not exactly comparable, 22.5 percent of women in the highest caffeine intake category were classified as low to moderate consumers when coffee was the measure of exposure.
The distribution of potential confounding variables by levels of caffeine intake is shown in table 3. Women who used oral contraceptives within the last 12 months prior to the starting time had a higher intake, as did those who were employed full time. There were variations by educational level, but no coherent pattern emerged. Those who drank more caffeinated beverages also had a greater alcohol consumption and smoked more, but they tended to have a lower level of sexual activity. Finally, the women's age was weakly associated with their caffeine intake. The distribution of potential confounding variables by levels of coffee consumption was similar to that of caffeine.
As summarized in table 4, after adjustment was made for potential confounders, a significantly increased odds ratio (odds ratio (OR) = 1.45) for subfecundity was observed among women drinking more than 500 mg of caffeine per day. When data were broken down by smoking status, the effect of drinking more than 500 mg was relatively stronger in smokers (OR = 1.56) than in nonsmokers (OR = 1.38). The effect varied among the different countries and was higher for Denmark and Germany and lower for southern Europe.
All analyses were repeated by using cutoff points for TTPs at 3.5, 9.5 (only data shown), 12.5, and 15.5 months; comparable results were obtained with those shown in table 4 for the first three cutoff points, but not for the last one (OR = 1.02).
When the exposure was ascertained from coffee consumption, a similar result was obtained after controlling for the same set of confounding variables. Women at high levels of exposure (five or more cups/ day) carried a significant risk (OR = 1.40, 95 percent confidence interval 1.01-1.95) of delayed conception (TCP >9.5 months).
In table 5 , the same analysis focused on the most recent waiting time episode can be seen. The emerging pattern is consistent with that observed in the first pregnancy, although the association was weaker. Women drinking more than 500 mg of caffeine per day had an increased risk of subfecundity (OR = 1.32), although the association was not statistically significant. A comparable result (OR = 1.26) was observed for the highest level of coffee consumption. Using Cox's regression (table 6), the risk ratio for the women who consumed more than 500 mg per day of caffeine at the start of the waiting time leading to their first pregnancy, after adjustment for main confounding factors, was 0.90, which represents an increase in the TCP of 11 percent. A similar result was observed when using coffee as the exposure variable. In relation to the most recent waiting time, the increase in the TCP was less than 10 percent for both coffee and caffeine intake.
In figures 1 and 2 are shown the distributions of the waiting time to the first pregnancy and the most recent waiting time according to the caffeine intake levels, after adjustment for main confounders. Overall within the first 3 months, 59 percent conceived; and 12 percent took more than 12 months to get pregnant in the first pregnancy. With regard to the most recent waiting time, 60 percent conceived within the first 3 months; and after 12 months, 16 percent were still not pregnant.
DISCUSSION
This study revealed an association of caffeine, at the upper level of intake, with reduced fecundity in a sample of fertile women who planned their pregnancy. This association was consistently observed in all countries, when using either coffee consumption or total caffeine intake as the exposure measure, and for waiting times to pregnancy related to the first and the most recent waiting time episodes.
Our data do not allow an assessment of individual effects of all three caffeinated beverages due to the small numbers of tea and cola drinkers. Given the high correlation between coffee and caffeine and since coffee was the main source of caffeine intake in our sample, it was not possible to test whether the detected effect was specifically related to coffee consumption or to the overall caffeine intake. We decided, therefore, to use the latter as the exposure measure for the main analysis since the use of coffee consumption might, to some extent, underestimate the exposure of • OR, odds ratio; Cl, confidence Interval. t Odds ratios were adjusted by women's age in years (£20, 21-25, 26-30, £31), use of oral contraceptives In the 12 months prior to the starting time (yes/no), cigarette smoking (no, 0-10, £11) and country.
t Odds ratios were adjusted by the same variables listed above except country. • OR, odds ratio; Cl, confidence interval. t Odds ratios were adjusted in both models by women's age in years (£20,21-25, 26-30, £31), use of oral contraceptives in the 12 months prior to the starting time (yes/no), cigarette smoking (no, 0-10, £11), parity (0, £1), working status, and country. some of the women in the highest level of caffeine intake (table 2) .
Measuring exposure accurately is particularly difficult in studies dealing with caffeine consumption. Although several urine and serum biomarkers for caffeine intake are available (32) and have been used to validate self-reported consumption as assessed by questionnaire (33, 34) , they cannot replace interview data at their present stage of development given their low sensitivity (27, 33) . In any case, the design of this study precluded the use of biomarkers to assess con- 
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Waiting time (months) FIGURE 1. Adjusted distribution of waiting time to the first pregnancy (estimated from the model shown in table 6) by levels of caffeine intake at the beginning of the waiting time.
sumption at the starting time since they measure only recent consumption. Calculation of the exposure took into account all caffeinated beverages and was categorized into four levels that differed from and were higher than those adopted in previously published US papers on caffeine and reproduction (14, (17) (18) (19) 21) , since coffee consumption in some of the participating European countries is much higher than in the United States (28) .
Our measure of total caffeine intake followed suggested recommendations for epidemiologic studies (24) but was based on ecologic data on average cup size, coffee mixtures, and brewing methods from each country since no individual data were available. Although our measurement constitutes a moderate improvement over other measurements used in previous studies, some misclassification is still present due to interindividual variations within each country. In addition, serum levels of caffeine metabolites differ for subjects reporting a similar caffeine intake due to differences in metabolic degradation rates (26) , further contributing to misclassification of exposure. A possible explanation for the apparent absence of effect when the cutoff point for subfecundity is 15.5 months can be found in the different nature of subfecundity in the population groups that conceive within 1 year of attempting compared with the population groups that conceive later. Healthy subjects belong to the former groups, having a normal fecundity apart from a relatively short delay for conception influenced by their exposure to external factors such as smoke, caffeine, and shift work. The latter groups of population experience a pathologic fecundity that, regardless of the exposure to external agents (or as a consequence of the exposure to very hazardous external agents), is affected by internal, organic alterations like tubal constriction, hormonal alteration, uterine dimorphism, psychological disorders, and so forth. Caffeine, among others, can be considered a weak risk factor that probably reduces fecundity by a certain fraction, but with- out being a sufficient cause of infertility. It is unlikely that a couple with severe internal alterations can conceive earlier than 1 year of attempting even though they do not drink any caffeinated beverages. An analogous reasoning may explain the weaker effect observed for the most recent waiting time since this episode includes women who never succeed in becoming pregnant.
The effect was relatively stronger in smokers than in nonsmokers, a result that agrees with a previous Danish study (20) but contradicts a very recent American study (19) . Although our results should be taken with caution given the low magnitude of the difference in ratios, it is possible that cigarette smoking interacts moderately with the effect of caffeine. Several studies have, however, suggested that cigarette smoking increases xanthine oxidase activity as reflected by the pattern of caffeine metabolites excreted in urine (1, 35) . If this is the case, the acceleration in the clearance of caffeine produced by smoking would act in the opposite direction, diminishing instead of exacerbating the effect. This is the mechanism suggested by Stanton and Gray (19) to explain their findings. In our case, an alternative interpretation may be advanced. Heavy coffee drinkers differ in. several ways from moderate drinkers and from those who do not drink at all (21, 24) , particularly with respect to cigarette smoking. Heavy coffee drinkers tend to smoke more. If we consider the possibility that some people who accurately report their coffee consumption underreport their tobacco consumption, the relatively greater effect of caffeine seen in smokers might be due to residual confounding as a consequence of misclassification in the level of smoking, which biases the effect away from the null, rather than an interaction between caffeine and tobacco.
The possibility that the observed association was partly due to unmeasured confounders cannot be ex-eluded. However, an important aspect of this study is that we controlled for the major, known risk factors for infertility (20, 25, 27) . In addition, other potential confounders such as working status, frequency of intercourse, and prevalence of pelvic inflammatory diseases were also included in multivariate analysis. Changes in trends of coffee consumption over time could also bias the results, but the magnitude of the association was not modified after including in the model the calendar year of the starting time period. Nutritional status, stress, or exercise may be potential confounders on which we had no data.
If the waiting TTP is long, a woman might modify spontaneously her consumption of caffeinated beverages, and therefore the recording of caffeine intake at the time of conception might be biased as a measurement of exposure (36). This was avoided in our study, however, since caffeine intake was estimated at the starting time of the first episode.
Differential recall, due to marked differences in the time elapsed from the starting time period up to the interview date, might be a source of misclassification bias. In the first pregnancy, this time ranged between 1 month and 31 years; but the mean time was approximately the same (11.9 years) for the different caffeine categories, and it differed only in 1.5 years between the fertile and subfertile women. However, since coffee consumption is not considered a reproductive hazard in Europe, any misclassification bias due to misreporting of caffeine consumption is most likely nondifferential and of a random type. Such a misclassification will, in most situations, bias results toward no effect values.
The exclusion of women with unplanned pregnancies might introduce bias since these women may be more fertile and also have higher exposure to caffeine and other lifestyle-related factors. Because the main objective of this study was to determine whether caffeine intake could delay conception in women who were trying to become pregnant, the definition of our outcome measure, TTP, does not allow the proper assessment of the effects of caffeine among women with accidental pregnancies. Nevertheless, the average daily caffeine consumption of women with planned pregnancies (339.8 mg/day) did not significantly differ from that of women with unplanned pregnancies (346.2 mg/day), and both samples showed a similar proportion of women with high caffeine intake (^500 mg/day). When the same multivariate analysis was repeated adding those unplanned pregnancies in which it was possible to estimate their TTP, the association between caffeine consumption and infertility showed a similar pattern (OR = 1.37, p = 0.035 for the highest caffeine intake category).
Our results are consistent with those reported in a previous Danish population-based survey (20) , which showed a negative effect (OR = 1.35) of caffeine on fertility (TTP > 12 months), but only in women who consumed eight or more cups of coffee/tea daily and also smoked. We found a similar effect in smokers, but at a lower level of caffeine consumption. In contrast to our study, planned and unplanned pregnancies were included, and the exposure measures were reported as average intake before pregnancy instead of at the starting time.
The results reported in two North American prospective studies (14, 18) and one retrospective study (19) also found a positive association but of a larger magnitude and at a lower level of consumption (from about one to three cups of coffee per day). The different study design and the select groups of subjects enrolled (volunteers, middle-and upper-class women, or employees in semiconductor manufacturing facilities vs. population-based samples in our study) limit the comparability with our results.
A large retrospective study (21) in pregnant women reported no association between those who consumed >7,000 mg of caffeine per month compared with those who consumed ^500 mg per month. Another study (22) concluded that no decrease in fertility occurred among coffee consumers of more than three cups per day. The categorizations used in both studies neither would have revealed an association in our own study population nor would have allowed the possibility of detecting a risk related to a high caffeine intake. Our study therefore has several strengths over previously published studies. The population was large and selected at random from the general population. This also allowed us to look for consistency of the effect in different countries with varying levels of exposure. Moreover, the analyses concerned the first pregnancy and the most recent waiting time, which was not restricted to women with proven fecundity. Frequency of sexual intercourse was controlled in the analysis, and our measurement of caffeine intake followed suggested recommendations for epidemiologic studies. Finally, the exposure was determined at the beginning of the waiting time and not during pregnancy.
Although some evidence has been gathered on an association between coffee consumption and delayed conception, a basic question still to be answered concerns the mechanism through which this association occurs. Information on potential ethiopathogenic mechanisms is scanty. It has been reported that caffeine decreases plasma levels of prolactin in nonpregnant healthy women (37) . Infertility may be associated with low serum prolactin concentration through hypoprolactinemia-induced inhibition of corpus lu-teum function or by direct ovarian inhibition. Coffee intake may also reduce levels of estrogens (38, 39), but this pathway would operate in an opposite direction by increasing gonadotropins and consequently ovarian stimulation. Regardless of the nature of the specific biologic mechanism involved, reduction of caffeine intake would prevent its associated risk of delayed conception if such a direct effect exists. However, if instead of operating through a biologic effect caffeine intake acts as a proxy for a stressful pattern of life, the potential benefits of reducing caffeine intake by itself are more doubtful. A more specific study aimed at ruling out the effect of caffeine intake in relation to other job-and life-related stress variables is needed.
